Concepedia

Daniel Oder

DO

15

Publications

1.1K

Citations

14

H-Index

2016

Active since

Affiliations

Universitätsklinikum Würzburg(Current)

Comprehensive Cancer Center Mainfranken

St Bartholomew's Hospital

Amsterdam UMC Location University of Amsterdam

University College London

Daniel Oder is an author at Universitätsklinikum Würzburg specializing in nephrology, medicine, and cardiovascular disease.

ORCID

Top concepts

Publications per year

2016–2018

15

Publications

15

Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study

Maarten Arends, Christoph Wanner, Derralynn Hughes et al. · Journal of the American Society of Nephrology · 2016 · 406 citations · Full text

Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study

Maarten Arends, Marieke Biegstraaten, Christoph Wanner et al. · Journal of Medical Genetics · 2018 · 119 citations · Full text

Lucerastat, an Iminosugar for Substrate Reduction Therapy: Tolerability, Pharmacodynamics, and Pharmacokinetics in Patients With Fabry Disease on Enzyme Replacement

Nicolas Guérard, Daniel Oder, Peter Nordbeck et al. · Clinical Pharmacology & Therapeutics · 2017 · 106 citations

Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factors

Maarten Arends, Marieke Biegstraaten, Derralynn Hughes et al. · PLoS ONE · 2017 · 103 citations · Full text

, , +13

Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After 1 Year

Jonas Müntze, Daniel Gensler, Octavian Maniuc et al. · Clinical Pharmacology & Therapeutics · 2018 · 91 citations · Full text

Rows per page

1–5 of 15